CAS 2226292-20-0

Giloralimab

CAS: 2226292-20-0

Giloralimab

Reinheit: ≥95%

Ref: 54-BUP20208

Giloralimab

CAS: 2226292-20-0

Giloralimab (ABBV-927) is a antibody targeting CD40 with anticancer activity for the study of triple-negative breast cancer and non-small cell lung cancer.

Reinheit: 95.6% (SDS-PAGE); 95.1% (SEC-HPLC) - 95.6% (SDS-PAGE); 95.1% (SEC-HPLC)

Farbe und Form: Liquid

Molekulargewicht: 146.34 kDa (Predicted)

Ref: TM-T82320

Giloralimab

CAS: 2226292-20-0

Reinheit: 95%

Ref: IN-DA02EOBR